166 related articles for article (PubMed ID: 21954892)
1. Hot melt granulation: a facile approach for monolithic osmotic release tablets.
Panda RR; Tiwary AK
Drug Dev Ind Pharm; 2012 Apr; 38(4):447-61. PubMed ID: 21954892
[TBL] [Abstract][Full Text] [Related]
2. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
3. Preparation of monolithic osmotic pump system by coating the indented core tablet.
Liu L; Che B
Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
[TBL] [Abstract][Full Text] [Related]
4. Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation.
Panda RR; Tiwary AK
Ther Deliv; 2010 Dec; 1(6):763-74. PubMed ID: 22834012
[TBL] [Abstract][Full Text] [Related]
5. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
6. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
7. Development of a controlled release low dose class II drug-Glipizide.
Jamzad S; Fassihi R
Int J Pharm; 2006 Apr; 312(1-2):24-32. PubMed ID: 16481135
[TBL] [Abstract][Full Text] [Related]
8. Development of a robust once-a-day glipizide matrix system.
Jamzad S; Fassihi R
J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
[TBL] [Abstract][Full Text] [Related]
9. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
10. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
11. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin complex osmotic tablet for glipizide delivery.
Gan Y; Pan W; Wei M; Zhang R
Drug Dev Ind Pharm; 2002 Sep; 28(8):1015-21. PubMed ID: 12378956
[TBL] [Abstract][Full Text] [Related]
13. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
[TBL] [Abstract][Full Text] [Related]
14. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of glipizide spheres and compacts from spheres prepared by cross-linking technique.
Garcia JG; Ghaly ES
P R Health Sci J; 2001 Mar; 20(1):25-30. PubMed ID: 11394213
[TBL] [Abstract][Full Text] [Related]
16. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
17. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
Patel GC; Asodaria KV; Patel HP; Shah DR
Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
[TBL] [Abstract][Full Text] [Related]
18. Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.
Liu Q; Fassihi R
J Pharm Pharmacol; 2009 Jul; 61(7):861-7. PubMed ID: 19589227
[TBL] [Abstract][Full Text] [Related]
19. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
[TBL] [Abstract][Full Text] [Related]
20. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
Ochoa L; Igartua M; Hernández RM; Gascón AR; Pedraz JL
J Pharm Pharm Sci; 2005 Jun; 8(2):132-40. PubMed ID: 16124924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
